Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: ENOTS who wrote (2313)	4/3/1998 10:48:00 PM
From: art slott	Read Replies (1) \| Respond to of 3725

Enots, great interview find. What was that website? Thats worth being in an imat PR. Replace 70 to 80% of all angiography. Btw Hopkins is rated the best hospital in US every year in US News and World Report. Art

To: ENOTS who wrote (2313)	4/4/1998 4:55:00 AM
From: Steven Durrington	Read Replies (3) \| Respond to of 3725

This is a Nuclear Medicine test to see the perfusion of radioactive isotope to the muscles of the heart. The isotope Technetium 99m is attached to a pharmaceutical (the tetrofosmin) that has an affinity with the cardiac muscle . The myocardium is the name for the heart muscle. Perfusion equals flow of blood to the tissues. In patients with acute heart problems, they often just do a resting study - patients get injected and the heart is imaged using a gamma camera. For most patients, they try to do a rest and exercise test, to see the difference in isotope distribution (and hence blood flow) to the heart in different states. The same sort of Nuclear Medicine test can be done using another isotope called Thallium. A more sensitive medical imaging type of test gauging cardiac blood flow is a PET scan using FDG. But it's a more expensive and a rarer procedure. Sorry to interrupt. I was just perusing over some medical imaging stocks on SI and found this one. Just took a little time out to answer your question. I might lurk for a while and find out a little more about this company - sounds kinda interesting. Regards, Durro